Abstract-Abnormal vascular smooth muscle (VSMC) prohferatlon 1s a key feature m diabetes-associated atherosclerotic disease Smce mttlc oxide mhlblts VSMC tone, mlgratlon, adhesion, and prohferatlon, we exammed the effects of high glucose on IL-l/3-induced NO release from VSMCs m culture Confluent smooth muscle cells, premcubated with either 5 mmol/L (n&l) or 20 mmol/L (mM) glucose for 48 hours, were stimulated with IL-lp Nltnte was measured m the culture medium after 24 hours. IL-l/3-induced a 15-fold increase m NO production m normal glucose medium Glucose (10 to 30 mmol/L (n&l)) significantly reduced the response to IL-l/3 High glucose (20 mmol/L (mM)) inhibited IL-l&evoked NO productlon by approximately 50% IL-l/3-stimulated ["HI cltrullme-forming actlvlty of the nitric oxide synthase (NOS) was also slgmficantly lower m high-glucose-exposed cells, and this was reflected m dlmmlshed cellular levels of NOS protein To assess the role of protem kmase C (PKC), membrane PKC activity was measured, and glucose (20 mmol/L (n&l)) slgmficantly increased it Immunoblottmg of the membranes revealed a glucose-induced increase m the PKC PII lsoform. 1,2-Dloctanoyl-glycerol, a PKC activator, mlmlcked the high-glucose effect on IL-lp-induced NO release, while staurosporme, a PKC mhlbltor, reversed it. Key Words: protein kmase C w mtnc oxide synthase n muscle w smooth n vascular w calcium w hyperglycemia N OSs synthesize NO from L-argmme m a tissue-specific and cell-specific manner ' 2 In blood vessels, two distinct NOS lsoforms have been identified The cNOS m endothehal cells 1s constltutlvely present and regulated by cytoplasnuc calcium levels m a transient fashion In VSMC, mductlon of a 1NOS capable of sustained production of NO occurs in response to a variety of agents and cytokmes.3 Induction of 1NOS m VSMC by cytokmes may have an adaptive role in the vascular response to Injury Cytokmes, such as mterleukm-lp (IL-l/3), are released during both atherogenesls and artenal injury' 1NOS actlvlty has been demonstrated m human atherosclerotic aotic homogenates and m VSMC of atherosclerotic plaques ' Furthermore, balloon injury (eg, postballoon cathetenzatlon) of artenes upregulates expression of 1NOS " In addition to its vasodatory role, NO mhlblts VSMC prohferation,* induces apoptosls, attenuates platelet aggreganon and cell adhesion to vascular walls," '" and negatwely regulates cell adhesion molecules m the vessel wall " Taken together, these observations suggest that mduchon of 1NOS dunng atherogenesls may reduce pathologcal VSMC prohferahon and plaque formation Conversely, deterioration of these mduchve responses may lead to exaggerated atherogemc changes Slgmficantly, accelerated atherosclerosis and hypertension are key abnormahtles m dabetes-associated vascular disease " " Chnlcal trial? have consistently concluded that hyperglycerma 1s a primary cause of dlabetlc vascular comphcatlons The goal of the present study, therefore, was to determme whether hyperglycenua interferes urlth cytokme mduchon of VSMC 1NOS and to study the mechamsm of this Interference Some of the toxic effects of hyperglycenna have been attnbuted to acnvanon of PKC by increased DAG synthesis 'W Glucose-Induced lmpanment of calcium regulatory processes has also been proposed to play a role.'" In this study, we exammed whether high glucose reduces cytokme-induced NOS acnvlty m VSMC and whether such regulation may be memated by PKC and calcium
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Materials and Methods

VSMC Preparation and
PKC Assay
Membrane fractions of VSMC were used to measure PKC actwlty a$ previously described I'*' Ahquots of membrane fractions were mcubated m a reaction buffer containing 50 PM Ac-myehn basic protein,'-"
4 mmol/L (mM) TnsHCl, (pH 7 5), 10 PM phorbol mynstate acetate, and 0 28 mg/mL phosphatldylsenne m Tmon X-100 micelIes and 2 5 pC1 of [Y-~*P] ATP (6000 Cl/mmol, DuPont) The reaction was started by the addmon of [ Y-~'P] ATP, and mcubation was carried out at 30°C for 10 mmutes Abquots of the reaction mixture were then spotted on phosphocellulose discs and washed with 1% phosphoric acid four times The filters were then counted m a scmtlllatmn counter, and the results were expressed as pmol/mm/mg of protem the amount of IL-l P-induced NO release when compared to control (NC medium, Fig 1A) . In preliminary experiments, the inhibitory effects of glucose was observed to be concentration-dependent, beginning at 10 mmol/L (mM) with maximal inhibition at 30 mmol/L (mM). We therefore chose 20 mmol/L (mM) glucose (HG medium) for all further experiments. Pretreatment of VSMC with equimolar concentration of mannitol (15 mmol/L (mM)), a poorly diffusible hexose, failed to inhibit IL-lP-stimulated NO release, a finding suggesting that increased extracellular osmolality was not responsible for the inhibitory actions of glucose (IL-l/3 in NG, 17.31'0.7 (nmoles nitrite/well); IL-l/3 + mannitol; 18.2t0.2 (nmoles nitrite/well)).
Western Blotting of iNOS and PKC Isoforms
HG medium also caused a reduction in NOS enzymatic activity; this reduction was due to a decrease in the amount of iNOS enzyme. In cell lysates from VSMC exposed to IL-lp (20 ng/mL), the conversion of L-arginine to L-citrulline was significantly increased, and this response in NG medium was significantly decreased (n=4) in IL-IP-treated cells pre-exposed to HG medium for 48 hours (Fig 1B) . The magnitude of the reduction in NOS activity was comparable to the reduction in IL-lP-stimulated nitrite accumulation. Citrullineforming activity of VSMC lysates was inhibited to basal values by 5 mmol/L (mM) AMT (2-amino-5,6-dihydro-6-methyl 4H-I,3 thiazine), a potent and selective inhibitor?' of iNOS (data not shown). Under the conditions of the enzymatic assay used here, any reduction in enzyme activity reflects a decrease in the amount of iNOS protein i"n the cell lysates. Since, iNOS is regulated mainly at the level of expression,"" we sought to determine whether high glucose inhibits IL-l@induced iNOS protein expression. As shown m Fig 2, 48 hours of mcubation with HG caused a significant reduction (n=4) in iNOS protem levels measured by Western blottmg. These data suggest that glucose exerts its inhibitory action at the level of expression of the NOS protein; this is then reflected m decreased NOS activity and NO production.
Elevated extracellular glucose has been reported to provoke increases m DAG" and snnultaneously to increase the enzyme activity, translocation,"" and phosphorylation of endogenous substrate?" of PKC in VSMC. It has been proposed that a reduced cytosohc redox state of NADH/NAD' may be mvolved m stimulating de novo synthesis of DAG from increased influx of glucose." It IS also known that PKC modulates iNOS induction m many different cell types"" mcludmg VSMC.'" " We therefore explored whether activation of PKC mediates some of the effects of glucose. PKC activity was sigmticantly enhanced (n=3) m the membrane fractions of VSMC treated with HG medium for 48 hours ( Fig  3A) . To determme which PKC isoform(s) might mediate the increase m membrane-bound PKC activity, we measured the amount of two of its isoforms (o and PII) m HG-treated VSMC membranes by Western blotting. PKC o( was most abundant but unchanged by glucose. However, HG sigmficantly increased (n=5) levels of the /311 isoform m the membrane fraction (Fig 3B) .
We used a membrane-permeable diacylglycerol, DOG (100 PM), as an activator of PKC; as seen m Fig 4, DOG sigmficantly decreased (n=5) the IL-lP-induced NO release. Staurosporme (100 nM), a widely used potent mhibitor of PKC, had no effect on IL-IP-stmlulated NO release m cells exposed to NG medmm, but it significantly attenuated (n=4) the inhibitory action of HG medium (Fig 4B) . Staurosporme per se had no significant effect on nitrite accumulation, a result that is consistent with previous reports.' Glucose-induced increases in DAG levels m vascular tissue may be prevented by concomitant exposure to pyruvate.23 It is proposed that pyruvate mediates this effect by ameliorating glucose-induced reductions in the cytosohc redox state." We therefore examined whether pyruvate would decrease the inhibitory effects of glucose on iNOS induction. VSMC were treated with or without pyruvate (2.5 mmol/L (mM)) in NG or HG medium for 48 hours, and the cells were treated with IL-l/3 as before. As is evident in Fig 5, pyruvate partially restored the IL-lp response in HG-treated VSMC while having no significant effect on cytokine-induced NO release from VSMC in NG medium. These results support the notion that iNOS inhibitory effects of glucose are mediated, in part, by activation of PKC.
Many studies have documented that hyperglycemia impairs calcium homeostasis in VSMC, resulting m a calcium overload.'6*32,31 In addition to regulating vascular tone, calcium also modulates gene expression:"" elevated intracellular calcium has been shown to inhibit iNOS induction in human chondrocytes.35 Therefore, we used BAPTA-AM, a cell-permeable calcmm chelator, to investigate the calcium dependency of high-glucose-induced iNOS inhibition. VSMC exposed to NG or HG medium for 48 hours were loaded with BAPTA-AM (50 PM) for 90 minutes at 37'C and then treated with IL-lp as before. When BAPTA-AM enters the cells, the -acetoxymethylester groups acre cleaved off, trapping BAPTA in the cytosol, where it then significantly reduces and maintains a low cytoplasmic calcium concentration.3".37 As seen in Fig 6 , intracellular calcium chelation had no effect on IL-lp-stimulated NO release in NG medium and significantly reversed (n=4) the high-glucose effect, although it did not normalize it. These observations were paralleled by changes in the iNOS protein levels (Fig 6B) The PKC family consists of at least 11 lsozymes and has been divided mto three subfamlhes the conventional PKCs (cPKC OL, /3, and 'y), which are dependent on calcium, DAG, and phosphohpld for activity, the novel PKCs (nPKC 6, E, q, 8, and II), which are calcium msensltlve but DAG and phospholipid sensitive, and the atypical PKCs (aPKC h, L, and 0 which are both calcium and DAG msensmve PKC lsoforms (Y, p, 6, E, and 6 have been demonstrated m VSMC,25 and glucose has been shown to translocate all of these lsoforms except 6 However, this effect was sustained more than 24 hours for only the /3 lsoform These findings, coupled with observations m dlabetlc rat vascular tissue and cells exposed to glucose for prolonged periods of time, clearly suggest a preferential actlvatlon of the PKC PI1 lsoform3' by high glucose Our results showing elevated PKC PII lsoform m glucose-treated VSMC concur with previous observations PKC 1s known to modulate 1NOS expression m different tissues It posltlvely regulates 1NOS expression m hepatocytes, macrophages,2H2" and avlan osteoblasts44 but mhlblts 1NOS mductlon m mesangal cells In VSMC, the role of PKC m regulating lNOS 1s unclear, some reports demonstrating mhlbltlon2't3' while others show both 3" This ambiguity may be explained by the dlverslty of PKC lsoforms, different endogenous substrates, and subcellular locahzatlon In contrast to our study, high glucose increases NO production m macrophages, mesanglal cells, and islet endotheha1 cells,45 m a PKC-dependent manner, findings suggesting that cell-specific factors may influence the nature of the response to glucose The exact mechanism of PKC-mediated mhlbltlon of lNOS still remains to be investigated PKC might affect the receptor and various slgnalmg cascades mltlated by IL-l/3 Evidence m the literature indicates that PKC mactlvates the IL-1 receptor m a human transformed B-cell line 46 PKC nught also affect downstream elements of the transduction pathway, such as NFKB, a key transcrlptlon factor mediating 1NOS mductlon Thus, high-glucose-mediated actlvatron of PKC might modulate a number of key processes involved m lNOS mductlon Calcium levels are increased m VSMC treated with high glucose 32 33 While calcium predommately upregulates certain genes, it 1s known to mhlblt others. Increased calcium mfluences 1NOS gene expression m certam cell types, mhlbltmg mductlon m human chondrocytes35 but upregulatmg It m avlan osteoblasts,44 findings suggesting a cell-specific effect In our expenrnents, intracellular calcium chelation with BAPTA-AM partially decreased the mhlbltory effects of glucose but mcreas- 
